India's pharma market grew about 12% in July, with monthly sales near ₹23,000 crore. Sheetal Sapale said cardiac drugs are benefiting as more people undergo cholesterol checks and preventive screening. Rising diabetes awareness, GLP-1 drugs such as semaglutide and demand for nutrition products are also reshaping chronic-care spending.